Individual patient data meta-analysis of hydroxyethyl starch 130/0.4–0.42 versus crystalloid for fluid resuscitation in patients with severe sepsis: A statistical analysis plan

Critical Care and Resuscitation

Volumn 16, Issue 2, 2014, Pages 96-103

  Hammond, Naomi E ^a,b,c   Haase, Nicolai ^d   Billot, Laurent ^a,c   Wetterslev, Jørn ^d   Saxena, Manoj K ^a,e   Finfer, Simon ^a,b,c   Perner, Anders ^d   Myburgh, John ^a,e,f  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d University of Copenhagen   (Denmark)

^e ST GEORGE HOSPITAL   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH DERIVATIVE; ISOTONIC SOLUTION; PLASMA SUBSTITUTE;

ARTICLE; CRITICAL ILLNESS; CRYSTALLOID; FLUID THERAPY; HUMAN; INTENSIVE CARE; META ANALYSIS; METHODOLOGY; RESUSCITATION; SEPSIS; TREATMENT OUTCOME;

CRITICAL ILLNESS; FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INTENSIVE CARE; ISOTONIC SOLUTIONS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PLASMA SUBSTITUTES; RESUSCITATION; SEPSIS;

EID: 84903751776     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Finfer S, Liu B, Taylor C, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 2010; 14: R185.
2. Myburgh J, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-11.
3. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/ 0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 2012; 367: 124-34.
4. Perner A, Haase N, Wetterslev J, Aneman A, et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S-Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial. Trials 2011; 12: 24.
5. Finfer S, Bellomo R. Why publish statistical analysis plans? Crit Care Resusc 2009; 11: 5-6.
6. Stuart EA. Matching methods for casual inference: a review and a look forward. Stat Sci 2010; 25: 1-21.
7. Thomas L, Peterson ED. The value of statistical analysis plans in observational research: defining high-quality research from the start. JAMA 2012; 308: 773-4.
8. Finfer S, Cass A, Gallagher M, et al; RENAL Study Investigators. The RENAL (Randomised Evaluation of Normal vs. Augmented Level of Replacement Therapy) study: statistical analysis plan. Crit Care Resusc 2009; 11: 58-66.
9. Finfer S, Heritier S; NICE Study Management Committee and SUGAR Study Executive Committee. The NICE-SUGAR (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation) Study: statistical analysis plan. Crit Care Resusc 2009; 11: 46-57.
10. Reade MC, Delaney A, Bailey MJ, et al. Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med 2010; 36: 11-21.
11. Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol 2002; 55: 86-94.
12. Vincent J, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-10.
13. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure — definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12.
14. Knaus W, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
15. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-63.
16. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002; 21: 1539-58.
17. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-6.